Mini-Guts Predict Cystic Fibrosis Patients' Response to Therapy (1 of 1) (image) American Association for the Advancement of Science Share Print E-Mail Caption The response to CFTR-targeted drugs measured by swelling of intestinal organoids differs between subjects with cystic fibrosis. This material relates to a paper that appeared in the 22 June 2016, issue of Science Translational Medicine, published by AAAS. The paper, by Johanna Dekkers at University Medical Center Utrecht in Utrecht, Netherlands, and colleagues was titled, "Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis." Credit Johanna Dekkers Usage Restrictions Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission. Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.